glp 1 and liver function GLP-1 drugs could reduce long-term sick leave: Study Mechanisms and possible hepatoprotective effects

Semaglutide is a prescription therapy used to support weight management and improve metabolic health

What the study showed The researchers performed a two-hour oral glucose tolerance test on 59 non-diabetic individuals with moderate to severe kidney disease and 39 controls

Wegovy is the version of semaglutide marketed to treat obesity by the longtime market leader in sales of GLP-1 diabetes and obesity treatments Novo Nordisk (NASDAQ Copenhagen: NOVO-B) , which also markets semaglutide to treat type 2 diabetes under the name Ozempic

Journal of Endocrinology and Metabolism , 3(1-2), 7-15

Graphical abstract

We love that it carries the National Eczema Association (NEA) Seal of Acceptance, which indicates that the designated product meets the required scientific criteria and is deemed safe for people with eczema and sensitive skin